Omentopexy after laparoscopic sleeve gastrectomy in children and adolescents: is it effective in reducing post-operative complications? - Scorecard - MDSpire

Omentopexy after laparoscopic sleeve gastrectomy in children and adolescents: is it effective in reducing post-operative complications?

  • By

  • Mohamed Mahfouz

  • Mohammad Daboos

  • Mohamed Abdelmaboud

  • Ibrahim Gamaan

  • Abd-Elfattah Kalmoush

  • Hatem Alsherbiny

  • Tharwat Hussien

  • Ahmed Azab

  • Mahmoud Mousa

  • Mohamed Emara

  • February 13, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Efficacy of Omentopexy Following Laparoscopic Sleeve Gastrectomy in Pediatric Patients: Can It Decrease Post-Operative Complications?

At a Glance

CategoryDetail
ConditionPediatric obesity with associated comorbidities
Key MechanismsOmentopexy stabilizes the gastric sleeve to prevent torsion and gastric stricture, potentially reducing postoperative gastrointestinal complications
Target PopulationPediatric patients under 18 years with BMI ≥40 kg/m2 or BMI ≥35 kg/m2 with comorbidities
Care SettingPediatric and general surgery departments in tertiary hospital settings

Key Highlights

  • Laparoscopic Sleeve Gastrectomy (LSG) is an effective surgical intervention for pediatric obesity when lifestyle and medical treatments fail.
  • Omentopexy during LSG may reduce early postoperative gastrointestinal symptoms such as leakage, vomiting, regurgitation, and food intolerance by preventing gastric sleeve torsion.
  • Randomized prospective study design with balanced groups using permuted block randomization to compare LSG with and without omentopexy.

Guideline-Based Recommendations

Diagnosis

  • Assess pediatric obesity using WHO growth charts for BMI.
  • Evaluate comorbidities including hypertension, diabetes, obstructive sleep apnea, and dyslipidemia.
  • Use GERD-Q scoring to quantify gastroesophageal reflux symptoms preoperatively.

Management

  • Consider LSG for pediatric patients with BMI ≥40 kg/m2 or BMI ≥35 kg/m2 with comorbidities after failure of lifestyle and medical treatments.
  • Perform omentopexy during LSG to stabilize the gastric sleeve and potentially reduce postoperative gastrointestinal complications.
  • Intraoperative leak testing with methylene blue injection is recommended.

Monitoring & Follow-up

  • Monitor early postoperative complications including leakage, nausea, vomiting, and regurgitation.
  • Measure postoperative hemoglobin levels on the first postoperative day to assess surgical blood loss.
  • Follow-up BMI and GERD-Q scores for 12 to 18 months postoperatively.

Risks

  • Potential postoperative gastrointestinal complications such as leakage, food intolerance, regurgitation, nausea, and vomiting.
  • Risk of gastric sleeve torsion and stricture without stabilization.
  • Surgical risks inherent to LSG including bleeding and anesthesia-related complications.

Patient & Prescribing Data

Morbidly obese pediatric patients under 18 years meeting BMI and comorbidity criteria.

Omentopexy added to LSG may reduce early postoperative gastrointestinal adverse symptoms and stabilize the gastric sleeve, potentially improving surgical outcomes.

Clinical Best Practices

  • Use permuted block randomization to ensure balanced patient allocation in clinical studies.
  • Perform omentopexy from 4 cm distal to the gastroesophageal junction to 4 cm proximal to the pylorus using running sutures during LSG.
  • Conduct thorough preoperative assessment including blood tests, respiratory function tests, and abdominal ultrasound.
  • Implement standardized postoperative monitoring protocols including symptom scoring and hemoglobin measurement.

References

Original Source(s)

Related Content